Verwandte Artikel zu Modern Biopharmaceuticals, 2 Parts: Recent Success...

Modern Biopharmaceuticals, 2 Parts: Recent Success Stories - Hardcover

 
9783527322831: Modern Biopharmaceuticals, 2 Parts: Recent Success Stories

Inhaltsangabe

This collection of high-profile contributions provides a unique insight into the development of novel, successful biopharmaceuticals.Outstanding authors, including Nobel laureate Robert Huber as well as prominent company researchers and CEOs, present valuable insider knowledge, limiting their scope to those procedures and developments with proven potential for the biotechnology industry. They cover all relevant aspects, from the establishment of biotechnology parks, the development of successful compounds and the implementation of efficient manufacturing processes, right up to the establishment of advanced delivery routes.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Dr. Jorg Knablein studied Biotechnology / Chemical Engineering at the Society for Biotechnology Research (GBF) in Braunschweig, Germany and Biochemistry at the Max-Planck-Institute for Biochemistry. He received his Ph.D. from the Max-Planck-Institute for Biochemistry in Martinsried / Munich where he worked in the group of Professor Robert Huber (Nobelprize laureate in 1988). Jorg Knablein holds a leading position in technology scouting at Bayer Schering Pharma AG, Berlin.


AWARDS:
Riedel-de Haen-Stiftung
Government / Ministry of Science
Nomination for the Max-Buchner-Award from DECHEMA (Society for Biotechnology and Chemical Engineering)
Winner of the McKinsey business plan contest

Von der hinteren Coverseite

This collection of high-profile contributions provides a unique insight into the development of novel, successful biopharmaceuticals.

Outstanding authors, including Nobel laureate Robert Huber as well as prominent company researchers and CEOs, present valuable insider knowledge, limiting their scope to those procedures and developments with proven potential for the biotechnology industry. They cover all relevant aspects, from the establishment of biotechnology parks, the development of successful compounds and the implementation of efficient manufacturing processes, right up to the establishment of advanced delivery routes.

From the contents:
• Modern biopharmaceuticals: research is the best medicine
• Modern biopharmaceutical development using stem cells, tissues, and whole animals
• Innovative development tools for modern biopharmaceuticals
• The rise of monoclonal antibodies – the premium class of biopharmaceuticals
• Smart solutions for global challenges – vaccine-based biopharmaceuticals
• Modern biopharmaceuticals – the holy grail for health and wealth
• From innovative tools to improved therapies – the success of second-generation biopharmaceuticals
• Biopharmaceutical manufacturing and downstream processing – how to uncork
bottlenecks

Aus dem Klappentext

This collection of high-profile contributions provides a unique insight into the development of novel, successful biopharmaceuticals.

Outstanding authors, including Nobel laureate Robert Huber as well as prominent company researchers and CEOs, present valuable insider knowledge, limiting their scope to those procedures and developments with proven potential for the biotechnology industry. They cover all relevant aspects, from the establishment of biotechnology parks, the development of successful compounds and the implementation of efficient manufacturing processes, right up to the establishment of advanced delivery routes.

From the contents:
• Modern biopharmaceuticals: research is the best medicine
• Modern biopharmaceutical development using stem cells, tissues, and whole animals
• Innovative development tools for modern biopharmaceuticals
• The rise of monoclonal antibodies – the premium class of biopharmaceuticals
• Smart solutions for global challenges – vaccine-based biopharmaceuticals
• Modern biopharmaceuticals – the holy grail for health and wealth
• From innovative tools to improved therapies – the success of second-generation biopharmaceuticals
• Biopharmaceutical manufacturing and downstream processing – how to uncork
  bottlenecks

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.